Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based studyKuniko Sunami, Takashi Kohno, Mayuko Kitami et al.|Cancer Science|2019Cited by 375
Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumabMasahito Kotaka, Tae Won Kim, Rui‐Hua Xu et al.|癌症：英文版|2016Cited by 15
Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancerRyo Otsuka, Masakazu Yamaguchi, Satoru Iwasa et al.|International Journal of Clinical Oncology|2019Cited by 5
Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy containing paclitaxel for advanced gastric cancer.Ryo Otsuka, Masakazu Yamaguchi, Satoru Iwasa et al.|Journal of Clinical Oncology|2019Cited by 0